Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03769961 · ClinicalTrials.gov registry record
Ataxia in Essential Tremor: Describing the Differences Between Disease Process and Treatment Effect
A clinical trial, sponsored by Oregon Health and Science University.
- Terminated
- Registry status
- 6
- Enrollment target
NCT03769961: Clinical Trial study, sponsored by Oregon Health and Science University.
NCT03769961 is a clinical trial that was terminated before completion, run by Oregon Health and Science University. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03769961 was terminated before completion, sponsored by Oregon Health and Science University.
- TERMINATED
- Registry status
- 6 participants
- Enrollment target
Study Summary
The proposed study aims to characterize ataxia occurring in essential tremor and essential tremor with DBS.
Primary Outcome
Compare the Scale of the Assessment and Rating of Ataxia (SARA) total score between DBS and no DBS participants with essential tremor. This 8-item scale rates gait (0-8 points), stance (0-6 points), sitting (0-4 points), speech disturbance (0-6 points), finger chase (0-4 points), nose-finger test (0-4 points), fast alternating hand movements (0-4 points), and heel-shin slide (0-4 points). Motor activists of the four extremities (items 5-8) assessments are performed bilaterally, mean values to ob
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2018-12-01 |
| Est. Completion | 2020-09-14 |
Why NCT03769961 stopped before completion
NCT03769961 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 6 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT03769961 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03769961 about?
NCT03769961 is a clinical study titled "Ataxia in Essential Tremor: Describing the Differences Between Disease Process and Treatment Effect". The proposed study aims to characterize ataxia occurring in essential tremor and essential tremor with DBS.
What is the current status of trial NCT03769961?
This trial is currently terminated. The enrollment target is 6 participants. The study started on 2018-12-01. Estimated completion is 2020-09-14.
What interventions are being tested in trial NCT03769961?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT03769961?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI